All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Growing its cardiovascular research portfolio, Portola Pharmaceuticals Inc. in-licensed an antithrombosis program from Millennium Pharmaceuticals Inc., the company from which it was spun. (BioWorld Today)